en

PRODUCT DETAIL

Deqsiga 100 mg/ml infúzny roztok

Code 9853E
MA number EU/1/25/1919/002
Product Form: sol inf 1x100 ml/10 g (liek.inj.skl.)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
MAH, country: Takeda Manufacturing Austria AG, Austria
Therapeutic Class: 59 - IMMUNOPRAEPARATA
ATC:
J ANTIINFECTIVES FOR SYSTEMIC USE
J06 IMMUNE SERA AND IMMUNOGLOBULINS
J06B IMMUNOGLOBULINS
J06BA Immunoglobulins, normal human
J06BA02 Immunoglobulins, normal human, for intravascular application
Shelf life: 24
Container: glass vial
Route of admin.: Intravenous use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 10a well-established use application
MA issued: 02.05.2025
Validity: 02.05.2030
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 21.05.2025
eu-flag.png sk-flag.png